Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$8.77 - $18.29 $5,218 - $10,882
-595 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$14.05 - $25.04 $210 - $375
15 Added 2.59%
595 $12,000
Q1 2021

May 13, 2021

BUY
$16.57 - $28.65 $1,077 - $1,862
65 Added 12.62%
580 $10,000
Q4 2020

Feb 12, 2021

BUY
$15.44 - $24.23 $7,951 - $12,478
515 New
515 $11,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $42.3M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.